ABBV AbbVie
Permanent stock page ↗Health Care · S&P 500
Next earnings: not announced yet
What 34 analyst firms say about AbbVie: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
33 rated views · 34 analyst/firm records · 34 firms
Radar score
- S&P 500 · Top Picks · 6MNot scored · Average target is not above the current price
- S&P 500 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 31 reports on ABBV from 22 analyst firms in the last 90 days (35 firms in the past year).
Comparing each firm's latest target with its previous one: 11 raised their price target, 6 left it unchanged and 2 have their first observed target in the past year.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: Canaccord Genuity raised its target from $290.00 (set 3 Aug 2026) to $338.00 on 2 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | Jasper Hellweg | Buy | 14 May 2026 | 270.00 USD |
| Barclays | Emily Field | Buy | 21 Oct 2026 | 325.00 USD |
| Berenberg | Luisa Hector | Buy | 11 May 2026 | 275.00 USD |
| Bernstein | Courtney Breen | Hold | 31 Jul 2026 | 230.00 USD |
| BMO Capital Markets | Evan Seigerman | Buy | 29 Sep 2026 | 300.00 USD |
| BNP Paribas Exane | Navann Ty | Hold | 11 Aug 2026 | 247.00 USD |
| Canaccord Genuity | Gary Nachman | Buy | 3 Aug 2026 | 290.00 USD |
| Cantor Fitzgerald | Carter Gould | Buy | 8 Oct 2026 | 290.00 USD |
| Citigroup | Geoff Meacham | Hold | 29 Sep 2026 | 260.00 USD |
| Daiwa | Narumi Nakagiri | Buy | 7 Aug 2026 | 250.00 USD |
| DBS | Nico Chen | Hold | 6 Mar 2026 | 230.00 USD |
| DZ Bank | Elmar Kraus | Buy | 3 Aug 2026 | 288.00 USD |
| Erste Group | Hans Engel | Buy | 5 Aug 2026 | — |
| Erste Group Bank | Unnamed analyst | Buy | 5 Aug 2026 | — |
| Evercore ISI | Gavin Clark-Gartner | Buy | 6 Jul 2026 | 260.00 USD |
| Freedom Capital Markets | Ilya Zubkov | Buy | 24 Jul 2026 | 285.00 USD |
| Goldman Sachs | Asad Haider | Hold | 23 Oct 2026 | 294.00 USD |
| Guggenheim | Vamil Divan | Buy | 9 Oct 2026 | 288.00 USD |
| HSBC | Rajesh Kumar | Buy | 10 Sep 2026 | 315.00 USD |
| JPMorgan | Chris Schott | Buy | 8 Oct 2026 | 300.00 USD |
| Leerink Partners | David Risinger | Buy | 5 Aug 2026 | 279.00 USD |
| Morgan Stanley | Terence Flynn | Buy | 7 Oct 2026 | 310.00 USD |
| Oppenheimer | Unnamed analyst | Hold | 3 Aug 2026 | 258.00 USD |
| Piper Sandler | David Amsellem | Buy | 7 Oct 2026 | 303.00 USD |
| RBC Capital Markets | Trung Huynh | Buy | 13 Oct 2026 | 280.00 USD |
| Redburn | Steven K Chesney | Buy | 4 Jun 2026 | 285.00 USD |
| Scotiabank | Louise Chen | Buy | 6 Oct 2026 | 320.00 USD |
| TD Cowen | Steve M Scala | Buy | 15 Jun 2026 | 280.00 USD |
| UBS | Michael Yee | Hold | 6 Oct 2026 | 275.00 USD |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Wells Fargo | Mohit Bansal | Buy | 17 Aug 2026 | 300.00 USD |
| William Blair | Matt Phipps | Buy | 28 Sep 2026 | — |
| Wolfe Research | Alexandria Hammond | Buy | 13 Aug 2026 | 300.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 298.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:18 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.